Artificial Pancreas - Medical Devices Pipeline Assessment, 2018

  • ID: 4601736
  • Report
  • 136 pages
  • GlobalData
1 of 4

FEATURED COMPANIES

  • Admetsys Corp
  • Boston University
  • Defymed SAS
  • Imperial College London
  • Nikkiso Co Ltd
  • TypeZero Technologies LLC
  • MORE
Artificial Pancreas - Medical Devices Pipeline Assessment, 2018

Summary

The author's Medical Devices sector report, “Artificial Pancreas - Medical Devices Pipeline Assessment, 2018" provides an overview of Artificial Pancreas currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Artificial Pancreas pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by a team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope
  • Extensive coverage of the Artificial Pancreas under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Artificial Pancreas and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry.
Reasons to buy

The report enables you to:
  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Artificial Pancreas under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory and estimated launch date.
READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Admetsys Corp
  • Boston University
  • Defymed SAS
  • Imperial College London
  • Nikkiso Co Ltd
  • TypeZero Technologies LLC
  • MORE
1 Table of Contents

2 Introduction
2.1 Artificial Pancreas Overview

3 Products under Development
3.1 Artificial Pancreas - Pipeline Products by Stage of Development
3.2 Artificial Pancreas - Pipeline Products by Territory
3.3 Artificial Pancreas - Pipeline Products by Regulatory Path
3.4 Artificial Pancreas - Pipeline Products by Estimated Approval Date
3.5 Artificial Pancreas - Ongoing Clinical Trials

4 Artificial Pancreas - Pipeline Products under Development by Companies
4.1 Artificial Pancreas Companies - Pipeline Products by Stage of Development
4.2 Artificial Pancreas - Pipeline Products by Stage of Development

5 Artificial Pancreas Companies and Product Overview
5.1 Admetsys Corp Company Overview
5.2 Advanced Biosensors-Ohio LLC (Inactive) Company Overview
5.3 Animas Corp Company Overview
5.4 Beta Bionics Inc Company Overview
5.5 Beta-O2 Technologies Ltd Company Overview
5.6 Bigfoot Biomedical Inc Company Overview
5.7 BioTex Inc Company Overview
5.8 Boston University Company Overview
5.9 Cerco Medical LLC Company Overview
5.10 Converge Biotech, Inc. Company Overview
5.11 Covalor Medical, LLC Company Overview
5.12 De Montfort University Company Overview
5.13 Debiotech SA Company Overview
5.14 Defymed SAS Company Overview
5.15 Diabeloop Company Overview
5.16 DreaMed Diabetes Ltd Company Overview
5.17 EOFlow Co Ltd Company Overview
5.18 Giner Inc Company Overview
5.19 Healios Inc Company Overview
5.20 Imperial College London Company Overview
5.21 Inreda Diabetic BV Company Overview
5.22 Insulet Corp Company Overview
5.23 Kencak LLC Company Overview
5.24 Medtronic plc Company Overview
5.25 Miromatrix Medical Inc Company Overview
5.26 Nikkiso Co Ltd Company Overview
5.27 Pacific Diabetes Technologies, Inc. Company Overview
5.28 Pancreum, LLC Company Overview
5.29 PharmaCyte Biotech Inc Company Overview
5.30 Polytechnic University of Valencia Company Overview
5.31 Rensselaer Polytechnic Institute Company Overview
5.32 Senseonics Holdings Inc Company Overview
5.33 Tandem Diabetes Care Inc Company Overview
5.34 TecMed Inc Company Overview
5.35 The Alfred Mann Foundation Company Overview
5.36 TypeZero Technologies LLC Company Overview
5.37 Ultradian Diagnostics LLC Company Overview
5.38 Universidad Autonoma de Madrid Company Overview
5.39 University of California San Francisco Company Overview
5.40 University of California Santa Barbara Company Overview
5.41 University of Cambridge Company Overview
5.42 University of Florida Company Overview
5.43 University of Newcastle Company Overview
5.44 XERIS Pharmaceuticals Inc Company Overview
5.45 Yale University Company Overview

6 Artificial Pancreas - Recent Developments
6.1 Jun 28, 2018: Medtronic Launches the MiniMed 670G System Performance Guarantee for Payers and Employers
6.2 Jun 25, 2018: Medtronic secures CE-Mark for MiniMed insulin delivery system
6.3 Jun 24, 2018: MiniMed 670G System Real-World Data Show Improved Time in Range and Reduced Lows and Highs Across All Patient Groups Including a 41 Percent Time in Range Improvement for Previous MDI Patients
6.4 Jun 24, 2018: Insulet Presents Positive Clinical Trial Results for the Omnipod Horizon Hybrid Closed-Loop System at the American Diabetes Association’s 78th Scientific Sessions
6.5 Jun 23, 2018: Diabeloop Insulin Delivery System May Significantly Improve Glycemic Control for People with Type 1 Diabetes
6.6 Jun 21, 2018: Medtronic Receives FDA Approval of New Pediatric Indication for the MiniMed 670G Hybrid Closed Loop System in Children Ages 7-13
6.7 Jun 19, 2018: Insulet to Unveil New Omnipod DASH System and Present Innovative Research at the American Diabetes Association’s 78th Scientific Sessions
6.8 Jun 05, 2018: Medtronic Presents Strategic Growth Roadmap at 2018 Investor Day; Outlines Plan to Create Shareholder Value

7 Appendix
7.1 Methodology
7.2 About
7.3 Contact
7.4 Disclaimer

List of Tables
Table 1: Artificial Pancreas - Pipeline Products by Stage of Development
Table 2: Artificial Pancreas - Pipeline Products by Territory
Table 3: Artificial Pancreas - Pipeline Products by Regulatory Path
Table 4: Artificial Pancreas - Pipeline Products by Estimated Approval Date
Table 5: Artificial Pancreas - Ongoing Clinical Trials
Table 6: Artificial Pancreas Companies - Pipeline Products by Stage of Development
Table 7: Artificial Pancreas - Pipeline Products by Stage of Development
Table 8: Admetsys Corp Pipeline Products & Ongoing Clinical Trials Overview
Table 9: Admetsys Smart Pancreas - Product Status
Table 10: Admetsys Smart Pancreas - Product Description
Table 11: Advanced Biosensors-Ohio LLC (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
Table 12: Artificial Pancreas - Product Status
Table 13: Artificial Pancreas - Product Description
Table 14: Animas Corp Pipeline Products & Ongoing Clinical Trials Overview
Table 15: Hypoglycemia-Hyperglycemia Minimizer System - Product Status
Table 16: Hypoglycemia-Hyperglycemia Minimizer System - Product Description
Table 17: Beta Bionics Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 18: iLet - Product Status
Table 19: iLet - Product Description
Table 20: iLet Bionic Pancreas - Insulin-only Version - Product Status
Table 21: iLet Bionic Pancreas - Insulin-only Version - Product Description
Table 22: Beta Bionics Inc - Ongoing Clinical Trials Overview
Table 23: iLet - Bihormonal Bionic Pancreas for the Treatment of Diabetes Post-Pancreatectomy in Children With Congenital Hyperinsulinism - A Pilot Study
Table 24: iLet - Feasibility of Outpatient Automated Blood Glucose Control with the Bionic Pancreas for Treatment of Cystic Fibrosis Related Diabetes
Table 25: iLet Bionic Pancreas - Insulin-only Version - Home-use Study to Evaluate the Efficacy of Insulin-only Configuration of iLet Bionic Pancreas System in Subjects with Type I Diabetes
Table 26: Beta-O2 Technologies Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 27: ßAir Bio-artificial Pancreas - Product Status
Table 28: ßAir Bio-artificial Pancreas - Product Description
Table 29: Beta-O2 Technologies Ltd - Ongoing Clinical Trials Overview
Table 30: ßAir Bio-artificial Pancreas - An Open Label, Pilot Investigation, to Assess the Safety and Efficacy of Transplantation of Macro-encapsulated Human Islets within the Bioartificial Pancreas Beta-Air in Patients with Type 1 Diabetes Mellitus
Table 31: Bigfoot Biomedical Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 32: Smartloop Automated Insulin Delivery System - Product Status
Table 33: Smartloop Automated Insulin Delivery System - Product Description
Table 34: BioTex Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 35: Artificial Pancreas - Product Status
Table 36: Artificial Pancreas - Product Description
Table 37: Boston University Pipeline Products & Ongoing Clinical Trials Overview
Table 38: Bionic Pancreas - Product Status
Table 39: Bionic Pancreas - Product Description
Table 40: Cerco Medical LLC Pipeline Products & Ongoing Clinical Trials Overview
Table 41: Islet Sheet - Product Status
Table 42: Islet Sheet - Product Description
Table 43: Converge Biotech, Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table 44: Bioartificial Pancreas System - Product Status
Table 45: Bioartificial Pancreas System - Product Description
Table 46: Covalor Medical, LLC Pipeline Products & Ongoing Clinical Trials Overview
Table 47: Artificial Pancreas - Product Status
Table 48: Artificial Pancreas - Product Description
Table 49: De Montfort University Pipeline Products & Ongoing Clinical Trials Overview
Table 50: InSmart Artificial Pancreas - Product Status
Table 51: InSmart Artificial Pancreas - Product Description
Table 52: Debiotech SA Pipeline Products & Ongoing Clinical Trials Overview
Table 53: Next Generation Artificial Pancreas - Product Status
Table 54: Next Generation Artificial Pancreas - Product Description
Table 55: Defymed SAS Pipeline Products & Ongoing Clinical Trials Overview
Table 56: MAILPAN - Product Status
Table 57: MAILPAN - Product Description
Table 58: Diabeloop Pipeline Products & Ongoing Clinical Trials Overview
Table 59: Diabeloop Artificial Pancreas - Product Status
Table 60: Diabeloop Artificial Pancreas - Product Description
Table 61: Diabeloop - Ongoing Clinical Trials Overview
Table 62: Diabeloop Artificial Pancreas - Crossover Evaluation of the Safety and the Efficacy of Artificial Pancreas Diabeloop for Three Months at Home in Comparison with Conventional Treatment by External Insulin Pump in Patients with Type 1 Diabetes
Table 63: DreaMed Diabetes Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 64: Glucositter - Product Status
Table 65: Glucositter - Product Description
Table 66: EOFlow Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 67: Disposable Artificial Pancreas System - Product Status
Table 68: Disposable Artificial Pancreas System - Product Description
Table 69: Giner Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 70: BAPIOS System - Product Status
Table 71: BAPIOS System - Product Description
Table 72: Healios Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 73: Bioengineered Pancreas - Product Status
Table 74: Bioengineered Pancreas - Product Description
Table 75: Imperial College London Pipeline Products & Ongoing Clinical Trials Overview
Table 76: Bio-inspired Artificial Pancreas - Product Status
Table 77: Bio-inspired Artificial Pancreas - Product Description
Table 78: Inreda Diabetic BV Pipeline Products & Ongoing Clinical Trials Overview
Table 79: Bi-Hormonal Artificial Pancreas - Product Status
Table 80: Bi-Hormonal Artificial Pancreas - Product Description
Table 81: Bi-Hormonal Artificial Pancreas - Lighter Version - Product Status
Table 82: Bi-Hormonal Artificial Pancreas - Lighter Version - Product Description
Table 83: Insulet Corp Pipeline Products & Ongoing Clinical Trials Overview
Table 84: Omnipod Horizon Hybrid Closed Loop System - Product Status
Table 85: Omnipod Horizon Hybrid Closed Loop System - Product Description
Table 86: Kencak LLC Pipeline Products & Ongoing Clinical Trials Overview
Table 87: BioArtificial Pancreas - Product Status
Table 88: BioArtificial Pancreas - Product Description
Table 89: Medtronic plc Pipeline Products & Ongoing Clinical Trials Overview
Table 90: MiniMed 640G System - Product Status
Table 91: MiniMed 640G System - Product Description
Table 92: MiniMed 670G - Product Status
Table 93: MiniMed 670G - Product Description
Table 94: Third-Generation Artificial Pancreas System - Product Status
Table 95: Third-Generation Artificial Pancreas System - Product Description
Table 96: Medtronic plc - Ongoing Clinical Trials Overview
Table 97: MiniMed 670G - A Crossover Study Comparing Two Automated Insulin Delivery System Algorithms (PID vs. PID + Fuzzy Logic) in Adolescents and Young Adults with Type 1 Diabetes
Table 98: MiniMed 670G - A Safety, Tolerability and Efficacy Study of Sernova's Cell Pouch for Clinical Islet Transplantation
Table 99: MiniMed 670G - Clinical Startup of the 670G Closed Loop Insulin Delivery System
Table 100: MiniMed 670G - Effect of Hybrid Closed-loop Insulin Delivery on Glucose Counterregulation in Long Standing Type 1 Diabetes: A Proof of Concept, Mechanistic, Single-arm Clinical Trial

List of Figures
Figure 1: Artificial Pancreas - Pipeline Products by Stage of Development
Figure 2: Artificial Pancreas - Pipeline Products by Territory
Figure 3: Artificial Pancreas - Pipeline Products by Regulatory Path
Figure 4: Artificial Pancreas - Pipeline Products by Estimated Approval Date
Figure 5: Artificial Pancreas - Ongoing Clinical Trials
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Admetsys Corp
  • Advanced Biosensors-Ohio LLC
  • Animas Corp
  • Beta Bionics Inc
  • Beta-O2 Technologies Ltd
  • Bigfoot Biomedical Inc
  • BioTex Inc
  • Boston University
  • Cerco Medical LLC
  • Converge Biotech, Inc.
  • Covalor Medical, LLC
  • De Montfort University
  • Debiotech SA
  • Defymed SAS
  • Diabeloop
  • DreaMed Diabetes Ltd
  • EOFlow Co Ltd
  • Giner Inc
  • Healios Inc
  • Imperial College London
  • Inreda Diabetic BV
  • Insulet Corp
  • Kencak LLC
  • Medtronic plc
  • Miromatrix Medical Inc
  • Nikkiso Co Ltd
  • Pacific Diabetes Technologies, Inc.
  • Pancreum, LLC
  • PharmaCyte Biotech Inc
  • Polytechnic University of Valencia
  • Rensselaer Polytechnic Institute
  • Senseonics Holdings Inc
  • Tandem Diabetes Care Inc
  • TecMed Inc
  • The Alfred Mann Foundation
  • TypeZero Technologies LLC
  • Ultradian Diagnostics LLC
  • Universidad Autonoma de Madrid
  • University of California San Francisco
  • University of California Santa Barbara
  • University of Cambridge
  • University of Florida
  • University of Newcastle
  • XERIS Pharmaceuticals Inc
  • Yale University
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll